Literature DB >> 11595124

Exogenous expression of p21(WAF1/CIP1) exerts cell growth inhibition and enhances sensitivity to cisplatin in hepatoma cells.

L F Qin1, I O Ng.   

Abstract

The effects of exogenous expression of p21(WAF1/CIP1) in hepatoma cells were examined. Two stably p21(WAF1/CIP1)-transfected clones and one clone transfected with expression vector only were used for study. Introduction of p21(WAF1/CIP1) resulted in significant cell growth inhibition, and the magnitude of the cell growth inhibition in these transfected cells was proportional to the level of p21(WAF1/CIP1) protein expressed. Exogenous p21(WAF1/CIP1) expression also significantly enhanced chemosensitivity to cisplatin. In addition, apoptosis occurred earlier in cells transfected with p21(WAF1/CIP1) after cisplatin treatment. These findings raise the potential that forced upregulation of p21(WAF1/CIP1) in hepatocellular carcinoma (HCC) may reduce the doses of cisplatin to achieve similar responses and suggest the possible use of p21(WAF1/CIP1) in HCC treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11595124     DOI: 10.1016/s0304-3835(01)00701-7

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

1.  Hepatomegaly in transgenic mice expressing the homeobox gene Cux-1.

Authors:  Gregory B Vanden Heuvel; Jennifer G Brantley; Neal I Alcalay; Madhulika Sharma; Gabor Kemeny; Joshua Warolin; Aric W Ledford; David M Pinson
Journal:  Mol Carcinog       Date:  2005-05       Impact factor: 4.784

2.  MIF4G domain containing protein regulates cell cycle and hepatic carcinogenesis by antagonizing CDK2-dependent p27 stability.

Authors:  C Wan; S Hou; R Ni; L Lv; Z Ding; X Huang; Q Hang; S He; Y Wang; C Cheng; X X Gu; G Xu; A Shen
Journal:  Oncogene       Date:  2013-12-16       Impact factor: 9.867

Review 3.  Resistance and gain-of-resistance phenotypes in cancers harboring wild-type p53.

Authors:  Michelle Martinez-Rivera; Zahid H Siddik
Journal:  Biochem Pharmacol       Date:  2011-12-26       Impact factor: 5.858

4.  Targeted p21WAF1/CIP1 activation by RNAa inhibits hepatocellular carcinoma cells.

Authors:  Mika Kosaka; Moo Rim Kang; Glen Yang; Long-Cheng Li
Journal:  Nucleic Acid Ther       Date:  2012-08-21       Impact factor: 5.486

Review 5.  MiRNAs-mediated cisplatin resistance in breast cancer.

Authors:  Xiu Chen; Peng Lu; Ying Wu; Dan-Dan Wang; Siying Zhou; Su-Jin Yang; Hong-Yu Shen; Xiao-Hui Zhang; Jian-Hua Zhao; Jin-Hai Tang
Journal:  Tumour Biol       Date:  2016-07-22

6.  Upregulation of p27 and its inhibition of CDK2/cyclin E activity following DNA damage by a novel platinum agent are dependent on the expression of p21.

Authors:  G He; J Kuang; Z Huang; J Koomen; R Kobayashi; A R Khokhar; Z H Siddik
Journal:  Br J Cancer       Date:  2006-11-07       Impact factor: 7.640

7.  MicroRNA-93-5p increases multidrug resistance in human colorectal carcinoma cells by downregulating cyclin dependent kinase inhibitor 1A gene expression.

Authors:  Shi-Jun Wang; Yun-Fei Cao; Zu-Qing Yang; Zhi-Yuan Jiang; Bin Cai; Jiao Guo; Sen Zhang; Xiao-Long Zhang; Feng Gao
Journal:  Oncol Lett       Date:  2016-12-06       Impact factor: 2.967

8.  Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells.

Authors:  Majid Momeny; Zahra Sabourinejad; Ghazaleh Zarrinrad; Farima Moghaddaskho; Haniyeh Eyvani; Hassan Yousefi; Shahab Mirshahvaladi; Ensieh M Poursani; Farinaz Barghi; Arash Poursheikhani; Leila Dardaei; Davood Bashash; Mahmoud Ghazi-Khansari; Seyyed M Tavangar; Ahmad R Dehpour; Marjan Yaghmaie; Kamran Alimoghaddam; Ardeshir Ghavamzadeh; Seyed H Ghaffari
Journal:  Sci Rep       Date:  2017-04-06       Impact factor: 4.379

9.  IFNγ-mediated inhibition of cell proliferation through increased PKCδ-induced overexpression of EC-SOD.

Authors:  Yoon-Jae Jeon; Hyun Yoo; Byung Hak Kim; Yun Sang Lee; Byeongwook Jeon; Sung-Sub Kim; Tae-Yoon Kim
Journal:  BMB Rep       Date:  2012-11       Impact factor: 4.778

10.  Acetyl-11-keto-β-boswellic acid enhances the cisplatin sensitivity of non-small cell lung cancer cells through cell cycle arrest, apoptosis induction, and autophagy suppression via p21-dependent signaling pathway.

Authors:  Minghe Lv; Xibing Zhuang; Qi Zhang; Yunfeng Cheng; Duojiao Wu; Xiangdong Wang; Tiankui Qiao
Journal:  Cell Biol Toxicol       Date:  2020-06-20       Impact factor: 6.691

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.